CRBU
$1.97
Caribou Biosciences, Inc.
Recent News
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Here is how CareCloud, Inc. (CCLD) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference
Executives from Caribou Biosciences (NASDAQ:CRBU) outlined upcoming clinical, regulatory, and financing milestones for its allogeneic cell therapy pipeline during a discussion at the Leerink Global Healthcare Conference in Miami. Management focused on plans to advance its lead program, vispa-cel, in
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of +14.11% and +56.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
EyePoint (EYPT) delivered earnings and revenue surprises of -3.85% and +15.89%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates
Urogen Pharma (URGN) delivered earnings and revenue surprises of +18.18% and +6.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?